Finger on the trigger to buy some stock, but not sure they are going to eclipse PFZ's 90% efficacy, although they do have the less rigid temp requirement for the vax. Plus, if mRNA tech works as well as it looks it might, their market cap should really take off given their whole platform is RNA based